- Home
- WOOF vs MDXG Comparison
WOOF vs MDXG Comparison
Compare WOOF & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WOOF | MDXG |
|---|---|---|
| Founded | 1965 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 627.3M | 625.6M |
| IPO Year | 2020 | 2007 |
Fundamental Metrics
Financial Performance| Metric | WOOF | MDXG |
|---|---|---|
| Price | $2.18 | $4.55 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | $3.47 | ★ $7.40 |
| AVG Volume (30 Days) | ★ 2.1M | 990.7K |
| Earning Date | 11-24-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 108.11 | 14.29 |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $5,961,467,000.00 | $418,630,000.00 |
| Revenue This Year | $0.47 | N/A |
| Revenue Next Year | $1.24 | $21.78 |
| P/E Ratio | $27.50 | ★ N/A |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $2.19 | $3.03 |
| 52 Week High | $3.88 | $7.97 |
Technical Indicators
Market Signals| Indicator | WOOF | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 28.26 | 49.09 |
| Support Level | N/A | $4.37 |
| Resistance Level | $2.45 | $4.76 |
| Average True Range (ATR) | 0.07 | 0.16 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 8.33 | 33.05 |
Price Performance
Historical ComparisonAbout WOOF Petco Health and Wellness Company Inc.
Petco Health and Wellness Co Inc is a pet specialty retailer focused on improving the lives of pets, pet parents, and its own partners with pet care centers in approximately 50 states, the District of Columbia and Puerto Rico. The Company also offers an expanded range of consumables, supplies, and services through its website and mobile app.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.